Skip to main content
. 2019 Oct 22;7(11):E1432–E1441. doi: 10.1055/a-0990-9488

Fig. 4a.

Fig. 4a

 Comparative adverse event rate of EUS-BD versus ERCP for treatment of distal malignant biliary obstruction. b Comparative reintervention rate of EUS-BD versus ERCP for treatment of distal malignant biliary obstruction.